Advanced
  Home Compare Reports

Comparison with Similar Reports

Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, ...

Publisher:        MarketsandMarkets

# of Pages:        417

Rating: 

1 User License $4,950

Publication Date:  December, 2021

Price:       $4,950 / User License




1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 49
1.3 MARKET SCOPE 50
1.3.1 MARKETS COVERED 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 51
1.4 CURRENCY 51
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 51
1.5 LIMITATIONS 52
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 53
2 RESEARCH METHODOLOGY 54
2.1 RESEARCH DATA 54
FIGURE 1 RESEARCH DESIGN 54
2.1.1 SECONDARY DATA 55
2.1.1.1 Secondary sources 56
2.1.2 PRIMARY DATA 56
2.1.2.1 Primary sources 57
2.1.2.2 Key data from primary sources 58
2.1.2.3 Key industry insights 58
2.1.2.4 Breakdown of primary interviews: By company type, designation, and region 59
2.2 MARKET SIZE ESTIMATION 59
FIGURE 2 REVENUE SHARE ANALYSIS ILLUSTRATION: F. HOFFMANN-LA ROCHE LTD. 60
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF HOME HEALTHCARE PRODUCTS AND SERVICES 60
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 61
FIGURE 5 TOP-DOWN APPROACH 62
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 63
FIGURE 6 DATA TRIANGULATION METHODOLOGY 63
2.4 MARKET SHARE ANALYSIS 63
2.5 ASSUMPTIONS FOR THE STUDY 64
2.6 LIMITATIONS 64
2.6.1 METHODOLOGY-RELATED LIMITATIONS 64
2.7 RISK ASSESSMENT 65
TABLE 2 RISK ASSESSMENT: HOME HEALTHCARE MARKET 65
2.8 COVID-19 HEALTH ASSESSMENT 65
2.9 COVID-19 ECONOMIC ASSESSMENT 65
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 66
FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY 66
3 EXECUTIVE SUMMARY 68
FIGURE 9 HOME HEALTHCARE MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION) 68
FIGURE 10 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD BILLION) 69
FIGURE 11 HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD BILLION) 69
FIGURE 12 HOME HEALTHCARE MARKET, BY INDICATION, 2021 VS. 2026 (USD BILLION) 70
FIGURE 13 HOME HEALTHCARE MARKET, BY REGION, 2021 VS. 2026 (USD BILLION) 70
4 PREMIUM INSIGHTS 72
4.1 HOME HEALTHCARE MARKET OVERVIEW 72
FIGURE 14 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 72
4.2 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 73
FIGURE 15 INHALERS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 73
4.3 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY MOBILITY CARE PRODUCT AND COUNTRY (2020) 74
FIGURE 16 WHEELCHAIRS DOMINATED THE ASIA PACIFIC HOME HEALTHCARE MARKET IN 2020 74
4.4 HOME HEALTHCARE MARKET, BY SERVICE, 2021–2026 75
FIGURE 17 INFUSION THERAPY SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026) 75
4.5 HOME HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 75
FIGURE 18 JAPAN IS THE FASTEST-GROWING MARKET FOR HOME HEALTHCARE 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 76
FIGURE 19 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 76
5.2.1 DRIVERS 77
5.2.1.1 Rapid growth in the elderly population and the rising incidence of chronic diseases 77
TABLE 3 OVERVIEW OF THE GERIATRIC POPULATION (MILLION) 77
FIGURE 20 GERIATRIC POPULATION, BY COUNTRY, 2010 VS. 2019 (% OF THE TOTAL POPULATION) 77
5.2.1.2 Rising R&D investments resulting in technologically advanced devices 78
TABLE 4 PRODUCT LAUNCHES 79
FIGURE 21 R&D EXPENDITURE (% OF TOTAL REVENUE), BY KEY PLAYER, 2019. VS 2020 79
5.2.1.3 Growing need for cost-effective healthcare delivery due to the increasing healthcare costs 80
5.2.1.4 Outbreak of the COVID-19 pandemic 80
5.2.2 RESTRAINTS 81
5.2.2.1 Changing reimbursement policies 81
5.2.2.2 Limited insurance coverage 82
5.2.2.3 Patient safety concerns 82
5.2.3 OPPORTUNITIES 82
5.2.3.1 Rising focus on telehealth 82
5.2.3.2 Untapped developing regions 83
5.2.3.3 Growing demand for home care therapeutic devices 83
5.2.3.4 Growing demand for home sleep apnea tests (HSATs) 84
5.2.3.5 Growing preference for home hemodialysis treatment 85
5.2.4 CHALLENGES 86
5.2.4.1 Shortage of homecare workers 86
5.3 RANGES/SCENARIOS 86
5.3.1 HOME HEALTHCARE MARKET 86
FIGURE 22 PESSIMISTIC SCENARIO 86
FIGURE 23 OPTIMISTIC SCENARIO 87
FIGURE 24 REALISTIC SCENARIO 87
5.4 REGULATORY ANALYSIS 88
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES 88
5.4.1 NORTH AMERICA 88
5.4.1.1 US 88
TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA 89
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 89
FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 90
5.4.1.2 Canada 90
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
FIGURE 26 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA 91
5.4.2 EUROPE 91
FIGURE 27 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES 92
5.4.3 ASIA PACIFIC 92
5.4.3.1 Japan 92
TABLE 9 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN 92
5.4.3.2 China 93
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES 93
5.4.3.3 India 94
5.5 PORTER’S FIVE FORCES ANALYSIS: PULSE OXIMETERS MARKET 95
TABLE 11 PORTER’S FIVE FORCES ANALYSIS FOR THE PULSE OXIMETERS MARKET 95
5.5.1 THREAT OF NEW ENTRANTS 95
5.5.2 THREAT OF SUBSTITUTES 96
5.5.3 BARGAINING POWER OF SUPPLIERS 96
5.5.4 BARGAINING POWER OF BUYERS 96
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.6 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET 97
TABLE 12 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET 97
5.6.1 THREAT OF NEW ENTRANTS 97
5.6.2 THREAT OF SUBSTITUTES 97
5.6.3 BARGAINING POWER OF BUYERS 97
5.6.4 BARGAINING POWER OF SUPPLIERS 97
5.6.5 DEGREE OF COMPETITION 98
5.7 TECHNOLOGY ANALYSIS 98
5.8 VALUE CHAIN ANALYSIS 99
FIGURE 28 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE 99
5.9 SUPPLY CHAIN ANALYSIS 100
FIGURE 29 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 101
5.10 PATENT ANALYSIS 101
5.10.1 PATENT GRANTED TRENDS FOR HOME HEALTHCARE 101
FIGURE 30 PATENT GRANTED TRENDS, JANUARY 2011–NOVEMBER 2021 102
5.10.2 JURISDICTION AND TOP APPLICANT ANALYSIS 102
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PULSE OXIMETER PATENTS, JANUARY 2011—NOVEMBER 2021 103
5.11 TRADE ANALYSIS 103
TABLE 13 IMPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD MILLION) 104
TABLE 14 EXPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD MILLION) 104
5.12 PRICING ANALYSIS 105
TABLE 15 PRICE RANGE FOR HOME CARE DEVICES, BY COUNTRY 105
TABLE 16 PRICES OF HEARING AIDS (2021) 109
5.13 ECOSYSTEM ANALYSIS 110
FIGURE 32 HOME HEALTHCARE DEVICES MARKET: ECOSYSTEM ANALYSIS 110
5.13.1 ROLE IN THE ECOSYSTEM 111
FIGURE 33 KEY PLAYERS IN THE HOME HEALTHCARE ECOSYSTEM 111
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 112
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR HOME HEALTHCARE PRODUCT MANUFACTURERS OR SERVICE PROVIDERS 112
FIGURE 34 REVENUE SHIFT FOR HOME HEALTHCARE PRODUCTS AND SERVICES 112
TABLE 17 ADJACENT MARKETS AND THEIR CURRENT GROWTH 112
6 HOME HEALTHCARE MARKET, BY PRODUCT 113
6.1 INTRODUCTION 114
TABLE 18 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD BILLION) 114
TABLE 19 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD BILLION) 114
TABLE 20 HOME HEALTHCARE PRODUCTS MARKET, BY REGION,
2018–2020 (USD BILLION) 115
TABLE 21 HOME HEALTHCARE PRODUCTS MARKET, BY REGION,
2021–2026 (USD BILLION) 115
6.2 THERAPEUTIC PRODUCTS 115
TABLE 22 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 116
TABLE 23 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 116
TABLE 24 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION,
2018–2020 (USD BILLION) 117
TABLE 25 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION,
2021–2026 (USD BILLION) 117
6.2.1 DIALYSIS EQUIPMENT 117
6.2.1.1 Dialysis equipment has gained significance due to its improved clinical outcomes and better quality of life for patients 117
TABLE 26 DIALYSIS EQUIPMENT MARKET, BY REGION, 2018–2020 (USD MILLION) 118
TABLE 27 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021–2026 (USD MILLION) 119
6.2.2 WOUND CARE PRODUCTS 119
6.2.2.1 Decreased cost and higher convenience and comfort of home care will ensure the growth of this segment 119
TABLE 28 WOUND CARE PRODUCTS MARKET, BY REGION, 2018–2020 (USD MILLION) 120
TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION) 120
6.2.3 IV EQUIPMENT 120
6.2.3.1 IV equipment facilitates the delivery of antibiotics, fluid replacements, and chemotherapy with accuracy 120
TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2018–2020 (USD MILLION) 121
TABLE 31 IV EQUIPMENT MARKET, BY REGION, 2021–2026 (USD MILLION) 121
6.2.4 SLEEP APNEA THERAPEUTIC DEVICES 122
6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market growth 122
TABLE 32 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 123
TABLE 33 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 123
6.2.5 INSULIN DELIVERY DEVICES 123
6.2.5.1 High incidence of diabetes to drive the insulin delivery devices market 123
TABLE 34 INSULIN DELIVERY DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 124
TABLE 35 INSULIN DELIVERY DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 124
6.2.6 OXYGEN DELIVERY SYSTEMS 124
6.2.6.1 Technological advancements in oxygen therapy products to drive the market 124
TABLE 36 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION,
2018–2020 (USD MILLION) 125
TABLE 37 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION) 125
6.2.7 INHALERS 126
6.2.7.1 High incidence of asthma is the major factor driving market growth 126
TABLE 38 INHALERS MARKET, BY REGION, 2018–2020 (USD MILLION) 126
TABLE 39 INHALERS MARKET, BY REGION, 2021–2026 (USD MILLION) 127
6.2.8 NEBULIZERS 127
6.2.8.1 Nebulizers are more effective as compared to oral dosages 127
TABLE 40 NEBULIZERS AVAILABLE IN THE MARKET 127
TABLE 41 NEBULIZERS MARKET, BY REGION, 2018–2020 (USD MILLION) 129
TABLE 42 NEBULIZERS MARKET, BY REGION, 2021–2026 (USD MILLION) 129
6.2.9 VENTILATORS 129
6.2.9.1 Home care ventilators are convenient and can be used in the comfort of the patient’s home 129
TABLE 43 VENTILATORS MARKET, BY REGION, 2018–2020 (USD MILLION) 130
TABLE 44 VENTILATORS MARKET, BY REGION, 2021–2026 (USD MILLION) 130
6.2.10 OTHER THERAPEUTIC PRODUCTS 131
TABLE 45 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION,
2018–2020 (USD MILLION) 131
TABLE 46 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION,
2021–2026 (USD MILLION) 132
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS 132
TABLE 47 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 133
TABLE 48 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 134
TABLE 49 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2018–2020 (USD BILLION) 135
TABLE 50 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2021–2026 (USD BILLION) 135
6.3.1 BLOOD GLUCOSE MONITORS 135
6.3.1.1 Increasing prevalence of diabetes to drive the market growth 135
TABLE 51 BLOOD GLUCOSE MONITORS MARKET, BY REGION,
2018–2020 (USD MILLION) 136
TABLE 52 BLOOD GLUCOSE MONITORS MARKET, BY REGION,
2021–2026 (USD MILLION) 137
6.3.2 HEARING AIDS 137
6.3.2.1 High incidence of hearing impairment to drive the market 137
TABLE 53 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020,
BY AGE GROUP 138
TABLE 54 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP (10-YEAR RANGE) 138
TABLE 55 GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP 139
TABLE 56 HEARING AIDS MARKET, BY REGION, 2018–2020 (USD MILLION) 139
TABLE 57 HEARING AIDS MARKET, BY REGION, 2021–2026 (USD MILLION) 139
6.3.3 BLOOD PRESSURE MONITORS 140
6.3.3.1 Increasing number of patients with hypertension and amplified occurrence of cardiovascular diseases to drive the market growth 140
TABLE 58 BLOOD PRESSURE MONITORS MARKET, BY REGION,
2018–2020 (USD MILLION) 141
TABLE 59 BLOOD PRESSURE MONITORS MARKET, BY REGION,
2021–2026 (USD MILLION) 141
6.3.4 ECG/EKG DEVICES 141
6.3.4.1 High prevalence of cardiovascular diseases to drive the market 141
TABLE 60 ECG/EKG DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION) 142
TABLE 61 ECG/EKG DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 143
6.3.5 OVULATION & PREGNANCY TEST KITS 143
6.3.5.1 Privacy, convenience, accessibility, and quick results to drive the market for ovulation and pregnancy test kits 143
TABLE 62 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION,
2018–2020 (USD MILLION) 143
TABLE 63 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION,
2021–2026 (USD MILLION) 144
6.3.6 PULSE OXIMETERS 144
6.3.6.1 Pulse oximeters are used to measure oxygen saturation in the blood 144
TABLE 64 PULSE OXIMETERS OFFERED BY MAJOR PLAYERS 145
TABLE 65 PULSE OXIMETERS MARKET, BY REGION, 2018–2020 (USD MILLION) 145
TABLE 66 PULSE OXIMETERS MARKET, BY REGION, 2021–2026 (USD MILLION ) 145
6.3.7 HEART RATE MONITORS 146
6.3.7.1 Ability to continuously monitor critical cardiac parameters to drive the demand for heart rate monitors 146
TABLE 67 HEART RATE MONITORS MARKET, BY REGION, 2018–2020 (USD MILLION) 146
TABLE 68 HEART RATE MONITORS MARKET, BY REGION, 2021–2026 (USD MILLION) 146
6.3.8 COAGULATION MONITORING PRODUCTS 147
6.3.8.1 Coagulation monitors are used for routine management of prothrombin time/international normalized ratio for safe and effective management 147
TABLE 69 COAGULATION MONITORING PRODUCTS MARKET, BY REGION,
2018–2020 (USD MILLION) 147
TABLE 70 COAGULATION MONITORING PRODUCTS MARKET, BY REGION,
2021–2026 (USD MILLION) 148
6.3.9 FETAL MONITORING DEVICES 148
6.3.9.1 Remote-based care by portable fetal monitoring systems to drive market growth 148
TABLE 71 FETAL MONITORING DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 149
TABLE 72 FETAL MONITORING DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 150
6.3.10 HIV TEST KITS 150
6.3.10.1 Rising prevalence of HIV to drive the market 150
TABLE 73 HIV TEST KITS MARKET, BY REGION, 2018–2020 (USD MILLION) 150
TABLE 74 HIV TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION) 151
6.3.11 HOLTER & EVENT MONITORS 151
6.3.11.1 Rising awareness of preventive care and technological advancements to drive the market 151
TABLE 75 HOLTER & EVENT MONITORS MARKET, BY REGION,
2018–2020 (USD MILLION) 151
TABLE 76 HOLTER & EVENT MONITORS MARKET, BY REGION,
2021–2026 (USD MILLION) 152
6.3.12 TEMPERATURE MONITORING DEVICES 152
6.3.12.1 Technological innovations and increasing awareness on the use of temperature monitoring devices for personal care to drive market growth 152
TABLE 77 TEMPERATURE MONITORING DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 152
TABLE 78 TEMPERATURE MONITORING DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 153
6.3.13 CHOLESTEROL TESTING PRODUCTS 153
6.3.13.1 Rising obesity levels and the incidence of cardiovascular disorders are supporting market growth 153
TABLE 79 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 154
TABLE 80 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 154
6.3.14 DRUG & ALCOHOL TEST KITS 154
6.3.14.1 Rising consumption of drugs among teens to support market growth 154
TABLE 81 RECENT APPROVALS FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES 155
TABLE 82 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION,
2018–2020 (USD MILLION) 155
TABLE 83 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION,
2021–2026 (USD MILLION) 156
6.3.15 PEAK FLOW METERS 156
6.3.15.1 Peak flow meters are used to monitor a person’s ability to breathe 156
TABLE 84 PEAK FLOW METERS MARKET, BY REGION, 2018–2020 (USD MILLION) 156
TABLE 85 PEAK FLOW METERS MARKET, BY REGION, 2021–2026 (USD MILLION) 157
6.3.16 COLON CANCER TEST KITS 157
6.3.16.1 High incidence of colorectal cancer to drive the market growth 157
TABLE 86 COLON CANCER TEST KITS MARKET, BY REGION, 2018–2020 (USD MILLION) 157
TABLE 87 COLON CANCER TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION) 158
6.3.17 ACTIVITY MONITORS & WRIST BANDS 158
6.3.17.1 Increasing prevalence of chronic diseases has resulted in a significant increase in the demand for activity monitors 158
TABLE 88 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION,
2018–2020 (USD MILLION) 158
TABLE 89 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION,
2021–2026 (USD MILLION) 159
6.3.18 EEG DEVICES 159
6.3.18.1 Emergence of epilepsy as a common neurological condition to drive the market for EEG devices 159
TABLE 90 EEG DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION) 160
TABLE 91 EEG DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 160
6.3.19 HOME SLEEP TESTING DEVICES 160
6.3.19.1 Cost-effectiveness of home-based sleep tests to fuel the growth of home sleep testing devices 160
TABLE 92 HOME SLEEP TESTING DEVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 161
TABLE 93 HOME SLEEP TESTING DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 162
6.3.20 HOME HEMOGLOBIN A1C TEST KITS 162
6.3.20.1 High incidence of diabetes to drive market growth 162
TABLE 94 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION,
2018–2020 (USD MILLION) 162
TABLE 95 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION,
2021–2026 (USD MILLION) 163
6.4 MOBILITY CARE PRODUCTS 163
TABLE 96 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 163
TABLE 97 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 164
TABLE 98 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY REGION, 2018–2020 (USD MILLION) 164
TABLE 99 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION) 164
6.4.1 WHEELCHAIRS 165
6.4.1.1 Increased preference for wheelchairs to support market growth 165
TABLE 100 WHEELCHAIRS MARKET, BY REGION, 2018–2020 (USD MILLION) 165
TABLE 101 WHEELCHAIRS MARKET, BY REGION, 2021–2026 (USD MILLION) 166
6.4.2 MOBILITY SCOOTERS 166
6.4.2.1 Mobility scooters help users to travel long distances 166
TABLE 102 MOBILITY SCOOTERS MARKET, BY REGION, 2018–2020 (USD MILLION) 166
TABLE 103 MOBILITY SCOOTERS MARKET, BY REGION, 2021–2026 (USD MILLION) 167
6.4.3 WALKERS & ROLLATORS 167
6.4.3.1 Walkers are used by the disabled and the elderly for additional support while walking 167
TABLE 104 WALKERS AND ROLLATORS MARKET, BY REGION,
2018–2020 (USD MILLION) 167
TABLE 105 WALKERS AND ROLLATORS MARKET, BY REGION,
2021–2026 (USD MILLION) 168
6.4.4 CRUTCHES 168
6.4.4.1 Axilla crutches are the most preferred as they are easy to use and are often used by people who have a temporary injury 168
TABLE 106 CRUTCHES MARKET, BY REGION, 2018–2020 (USD MILLION) 168
TABLE 107 CRUTCHES MARKET, BY REGION, 2021–2026 (USD MILLION) 169
6.4.5 CANES 169
6.4.5.1 Canes are the most common assistive devices 169
TABLE 108 CANES MARKET, BY REGION, 2018–2020 (USD MILLION) 169
TABLE 109 CANES MARKET, BY REGION, 2021–2026 (USD MILLION) 170
7 HOME HEALTHCARE MARKET, BY SERVICE 171
7.1 INTRODUCTION 172
TABLE 110 US: AVERAGE SENIOR CARE COST, BY TYPE AND DURATION, 2019 172
TABLE 111 HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD BILLION) 173
TABLE 112 HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD BILLION) 173
TABLE 113 HOME HEALTHCARE SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 174
TABLE 114 HOME HEALTHCARE SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 174
7.2 SKILLED NURSING 174
7.2.1 SKILLED NURSING SERVICES TO DOMINATE THE HOME HEALTHCARE SERVICES MARKET DURING THE FORECAST PERIOD 174
TABLE 115 SKILLED NURSING SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 175
TABLE 116 SKILLED NURSING SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 175
7.3 REHABILITATION THERAPY 175
7.3.1 REHABILITATION THERAPY SERVICES MAJORLY INCLUDE PHYSIOTHERAPY, OCCUPATIONAL THERAPY, AND SPEECH THERAPY 175
TABLE 117 REHABILITATION THERAPY SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 176
TABLE 118 REHABILITATION THERAPY SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 176
7.4 HOSPICE & PALLIATIVE CARE 177
7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE & PALLIATIVE CARE SERVICES 177
TABLE 119 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 177
TABLE 120 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 178
7.5 UNSKILLED CARE 178
7.5.1 UNSKILLED CARE SERVICES ARE COST-EFFECTIVE AND OFFER COMFORT AND SECURITY TO PATIENTS 178
TABLE 121 UNSKILLED CARE SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 179
TABLE 122 UNSKILLED CARE SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 179
7.6 RESPIRATORY THERAPY 179
7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET GROWTH 179
TABLE 123 RESPIRATORY THERAPY SERVICES MARKET, BY REGION,
2018–2020 (USD BILLION) 180
TABLE 124 RESPIRATORY THERAPY SERVICES MARKET, BY REGION,
2021–2026 (USD BILLION) 180
7.7 INFUSION THERAPY 181
7.7.1 HOME INFUSION IS A SAFE AND EFFECTIVE ALTERNATIVE TO IN-PATIENT CARE FOR VARIOUS DISEASE STATES AND THERAPIES 181
TABLE 125 INFUSION THERAPY SERVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 182
TABLE 126 INFUSION THERAPY SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 182
7.8 PREGNANCY CARE 182
7.8.1 PREGNANCY CARE SERVICES HELP EXPECTANT PARENTS TO MANAGE HIGH-RISK PREGNANCIES AND COMPLICATIONS 182
TABLE 127 PREGNANCY CARE SERVICES MARKET, BY REGION,
2018–2020 (USD MILLION) 183
TABLE 128 PREGNANCY CARE SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 184
8 HOME HEALTHCARE MARKET, BY INDICATION 185
8.1 INTRODUCTION 186
TABLE 129 HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD BILLION) 186
TABLE 130 HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD BILLION) 186
8.2 CANCER 187
8.2.1 HIGH PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 187
TABLE 131 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION) 187
TABLE 132 PROJECTED INCREASE IN THE GLOBAL NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2035 188
TABLE 133 HOME HEALTHCARE MARKET FOR CANCER, BY REGION,
2018–2020 (USD BILLION) 188
TABLE 134 HOME HEALTHCARE MARKET FOR CANCER, BY REGION,
2021–2026 (USD BILLION) 189
8.3 RESPIRATORY DISEASES 189
8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES IS A KEY FACTOR DRIVING MARKET GROWTH 189
TABLE 135 INCIDENCE OF TB, 2019 190
TABLE 136 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2020 (USD BILLION) 190
TABLE 137 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2021–2026 (USD BILLION) 191
8.4 MOVEMENT DISORDERS 191
8.4.1 AGING IS A RISK FACTOR FOR MOVEMENT DISORDERS 191
TABLE 138 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2018–2020 (USD BILLION) 191
TABLE 139 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2021–2026 (USD BILLION) 192
8.5 CARDIOVASCULAR DISEASES & HYPERTENSION 192
8.5.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT 192
TABLE 140 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION, BY REGION, 2018–2020 (USD BILLION) 193
TABLE 141 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION, BY REGION, 2021–2026 (USD BILLION) 193
8.6 PREGNANCY 193
8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH 193
TABLE 142 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION,
2018–2020 (USD BILLION) 194
TABLE 143 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION,
2021–2026 (USD BILLION) 194
8.7 WOUND CARE 195
8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET GROWTH 195
TABLE 144 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION,
2018–2020 (USD BILLION) 195
TABLE 145 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION,
2021–2026 (USD BILLION) 196
8.8 DIABETES 196
8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH 196
TABLE 146 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION,
2018–2020 (USD BILLION) 197
TABLE 147 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION,
2021–2026 (USD BILLION) 197
8.9 HEARING DISORDERS 197
8.9.1 PREVALENCE OF HEARING LOSS IS HIGHER IN THE AGING POPULATION 197
TABLE 148 GLOBAL INCIDENCE OF HEARING DISORDERS 198
TABLE 149 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2018–2020 (USD BILLION) 198
TABLE 150 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2021–2026 (USD BILLION) 198
8.10 OTHER INDICATIONS 199
TABLE 151 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,
2018–2020 (USD BILLION) 199
TABLE 152 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,
2021–2026 (USD BILLION) 200
9 HOME HEALTHCARE MARKET, BY REGION 201
9.1 INTRODUCTION 202
TABLE 153 HOME HEALTHCARE MARKET, BY REGION, 2018–2020 (USD BILLION) 202
TABLE 154 HOME HEALTHCARE MARKET, BY REGION, 2021–2026 (USD BILLION) 202
9.2 NORTH AMERICA 203
FIGURE 35 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT 203
TABLE 155 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY,
2018–2020 (USD BILLION) 204
TABLE 156 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY,
2021–2026 (USD BILLION) 204
TABLE 157 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE,
2018–2020 (USD BILLION) 204
TABLE 158 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE,
2021–2026 (USD BILLION) 204
TABLE 159 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 205
TABLE 160 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 205
TABLE 161 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 206
TABLE 162 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 207
TABLE 163 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 208
TABLE 164 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 208
TABLE 165 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 209
TABLE 166 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 209
TABLE 167 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 210
TABLE 168 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 210
TABLE 169 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 211
TABLE 170 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 211
9.2.1 US 212
9.2.1.1 The US dominates the North American home healthcare market 212
TABLE 171 US: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD BILLION) 213
TABLE 172 US: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD BILLION) 213
TABLE 173 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 214
TABLE 174 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 214
TABLE 175 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 215
TABLE 176 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 216
TABLE 177 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 217
TABLE 178 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 217
TABLE 179 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 218
TABLE 180 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 218
TABLE 181 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 219
TABLE 182 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 219
TABLE 183 US: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 220
TABLE 184 US: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 220
9.2.2 CANADA 221
9.2.2.1 Rising geriatric population in the country to drive market growth 221
TABLE 185 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 222
TABLE 186 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 222
TABLE 187 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 223
TABLE 188 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 223
TABLE 189 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 224
TABLE 190 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 225
TABLE 191 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 226
TABLE 192 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 226
TABLE 193 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 227
TABLE 194 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 227
TABLE 195 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 228
TABLE 196 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 228
TABLE 197 CANADA: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 229
TABLE 198 CANADA: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 229
9.3 EUROPE 230
TABLE 199 EUROPE: PERCENTAGE OF POPULATION AGED 60 AND OVER, 2017 VS. 2050 230
TABLE 200 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION,
2018–2020 (USD BILLION) 231
TABLE 201 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION,
2021–2026 (USD BILLION) 231
TABLE 202 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION) 231
TABLE 203 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION) 232
TABLE 204 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 232
TABLE 205 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 232
TABLE 206 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 233
TABLE 207 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 234
TABLE 208 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 235
TABLE 209 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 235
TABLE 210 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 236
TABLE 211 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 236
TABLE 212 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 237
TABLE 213 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 237
TABLE 214 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 238
TABLE 215 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 238
9.3.1 GERMANY 239
9.3.1.1 Germany to dominate the European home healthcare market 239
TABLE 216 GERMANY: KEY MACROINDICATORS 240
TABLE 217 GERMANY: HOME HEALTHCARE MARKET, BY TYPE,
2018–2020 (USD MILLION) 240
TABLE 218 GERMANY: HOME HEALTHCARE MARKET, BY TYPE,
2021–2026 (USD MILLION) 240
TABLE 219 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2018–2020 (USD MILLION) 241
TABLE 220 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 241
TABLE 221 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 242
TABLE 222 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 243
TABLE 223 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 244
TABLE 224 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 244
TABLE 225 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION) 245
TABLE 226 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 245
TABLE 227 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2018–2020 (USD MILLION) 246
TABLE 228 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 246
TABLE 229 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION,
2018–2020 (USD MILLION) 247
TABLE 230 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION,
2021–2026 (USD MILLION) 247

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127